Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

14 Mar 2022 · Paul Langley
Island Pharmaceuticals discuss the Dengue Fever pandemic
Island Pharmaceutical CEO Dr David Foster discusses the Dengue Fever pandemic from IR Department on Vimeo.
Read article
11 Mar 2022 · Jane Lowe
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
"The smart money in medicine: combatting fibrosis"
Read article
08 Mar 2022 · Cherie Hartley
IR Department celebrates International Women's Day 2022
YouTube video player
Read article
16 Feb 2022 · Paul Langley
Learn more about HaemaLogix’s ground-breaking KappaMab technology
KappaMab is a monoclonal antibody developed by HaemaLogiX to treat blood cancers, with an initial focus on multiple myeloma.
Read article
13 Jan 2022 · Admin
IRD Invest - Innovation and change
We are all part of a new era. After reaching a low point in mid-2020, the investment landscape has changed dramatically. Companies, like investment markets, are adapting. We want to illustrate how our...
Read article
20 Dec 2021 · Paul Langley
Wayne Finlayson, CEO Servatus Ltd., interview
INTRODUCTION: IR Department sat down with Dr Wayne Finlayson of Servatus Ltd to discuss his vision for the company, his 30 year career in the biopharmaceutical and biotechnology sector and life…
Read article
20 Oct 2021
Surge in growth stocks lifts investor relations activity
2021 has been a record year for the number of initial public offerings (IPOs), with more than 130 on the ASX so far and dozens more anticipated by the end of December. The heightened IPO activity was ...
Read article
21 Sep 2021 · Jane Lowe
Atomo Diagnostics (ASX: AT1) presents at IRD Invest
Atomo has supply agreements in place for tests targeting infectious diseases including HIV, COVID-19, and viral vs bacterial differentiation.
Read article
12 Aug 2021 · George Kopsiaftis
What will investors be looking out for this reporting period?
With another financial reporting season upon us, we thought it an opportune time to consider what the investment community will likely be focusing on as they contemplate how best to position their…
Read article
11 Aug 2021 · Cherie Hartley
The evolution of social media in crisis communications - Part Two: When the crisis hits
Following on from where I left off in Part One of this blog, which looked at the evolution of social media in crisis management and five key steps to prepare your company before a crisis hits, today
Read article